Back to search

Article

Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers

2019-01-07

Abstract excerpt

Patient-derived models are transforming translational cancer research. It is not clear if the emergence of patient-derived organoid (PDO) models can extend the utility of the widely used patient-derived xenograft (PDX). In addition, the utility of PDO models for serum biomarker discovery is not known. Here, we demonstrate that PDO models recapitulate the genomics, cell biology, glycomics and drug responses observe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
162efb81-1394-525d-a0bb-ff808fb99045
DOI
10.1101/513267
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkersDOI 10.1101/513267
Select a neighboring publication to make it the new centre.